|
Delayed
OTC Markets
12:35:50 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.9109 USD | +33.09% |
|
0.00% | +2.00% |
| 07/09 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| 31/08 | Cstone Pharmaceuticals Provides Updates on Cs2009 and Pipeline 2.0 Clinical Trials and Product Portfolio | CI |
Company Valuation: CStone Pharmaceuticals
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,845 | 4,882 | 2,628 | 2,759 | 6,980 | 7,331 | - | - |
| Change | - | -37.77% | -46.18% | 4.99% | 153.01% | 5.03% | - | - |
| Enterprise Value (EV) 1 | 7,249 | 4,551 | 1,950 | 2,404 | 6,404 | 6,353 | 3,308 | 3,159 |
| Change | - | -37.22% | -57.15% | 23.28% | 166.37% | -0.79% | -47.93% | -4.51% |
| P/E | - | -5.32x | -7.11x | -30.9x | -15.3x | -15.9x | 7.71x | -92x |
| PBR | 6.63x | 10.9x | 5.7x | - | 10.7x | - | - | - |
| PEG | - | - | 0.1x | 0.4x | -0x | 2.46x | -0x | 1x |
| Capitalization / Revenue | 32.2x | 10.1x | 5.67x | 6.78x | 25.9x | 17.3x | 4.26x | 7.67x |
| EV / Revenue | 29.7x | 9.45x | 4.2x | 5.9x | 23.8x | 15x | 1.92x | 3.3x |
| EV / EBITDA | -3.99x | -5.1x | -3.33x | -25.9x | -16.5x | -15.7x | 1.71x | 14.9x |
| EV / EBIT | -3.96x | -4.99x | -3.22x | -22.7x | -14.8x | -16.7x | 3x | -40.2x |
| EV / FCF | -4.57x | -7.43x | - | - | -19.5x | -20.2x | -16.7x | -25.7x |
| FCF Yield | -21.9% | -13.5% | - | - | -5.12% | -4.94% | -5.99% | -3.89% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | -0.77 | -0.29 | -0.07 | -0.31 | -0.29 | 0.5967 | -0.05 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 243.7 | 481.4 | 463.8 | 407.2 | 269.6 | 423.2 | 1,722 | 956.2 |
| EBITDA 1 | -1,818 | -892.9 | -585.4 | -92.72 | -388.6 | -405.2 | 1,937 | 212.3 |
| EBIT 1 | -1,829 | -912.1 | -605.6 | -106.1 | -432.6 | -381 | 1,102 | -78.51 |
| Net income 1 | -1,920 | -902.7 | -367.2 | -91.21 | -437 | -383.5 | 680.5 | -48.57 |
| Net Debt 1 | -596.2 | -331.1 | -677.7 | -354.7 | -576.3 | -977.7 | -4,023 | -4,172 |
| Reference price 2 | 6.737 | 4.096 | 2.061 | 2.161 | 4.736 | 4.599 | 4.599 | 4.599 |
| Nbr of stocks (in thousands) | 11,64,452 | 11,92,099 | 12,75,317 | 12,76,503 | 14,73,942 | 15,94,112 | - | - |
| Announcement Date | 08/06/22 | 26/04/23 | 23/04/24 | 27/03/25 | 26/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.94x | 4.15x | 9.74x | 0.5% | 7.73TCr | |
| 20.38x | 4.36x | 13.55x | 2.41% | 5.96TCr | |
| -17.37x | 25.93x | -16.84x | -.--% | 5.81TCr | |
| 34.33x | 11.68x | 22.39x | -.--% | 4.76TCr | |
| 20.59x | 4.55x | 12.98x | 0.71% | 4.53TCr | |
| 35.23x | 3.53x | 13.23x | -.--% | 3.19TCr | |
| 55.67x | 3.54x | 27.46x | -.--% | 2.53TCr | |
| 61.85x | 6.58x | 39.07x | -.--% | 2.09TCr | |
| 23.03x | 4.95x | 12.88x | -.--% | 1.56TCr | |
| Average | 27.96x | 7.70x | 14.94x | 0.4% | 4.24TCr | |
| Weighted average by Cap. | 21.86x | 8.56x | 11.45x | 0.56% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 2616 Stock
- CSPHF Stock
- Valuation CStone Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
